Trial Profile
An Open-Label Study to Assess the Effect of Omeprazole Administration on the Pharmacokinetics of VELCADE in Subjects With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Omeprazole
- Indications Non-Hodgkin's lymphoma; Solid tumours
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Millennium
- 04 Jun 2008 Status changed from in progress to completed.
- 12 Jul 2007 Status changed from recruiting to in progress.
- 31 Aug 2005 New trial record.